share_icon

If you need to inquire about Bayer product, please contact us through the following telephone:


Hotline: 400-810-0360 (available by mobile or telephone)


We will try our best to provide you the information about Bayer products, but we can't propose any specific diagnosis and treatment suggestions for patients' conditions. If you have any discomfort after medication, please go to see your doctor and receive timely medical treatment.


If you want to report a side effect or quality complaint, please contact your health care professional (e.g. treating physician or pharmacist) or your local health authority, Inquiries can also be directed to:


Email:AE_China@bayer.com


If you observe adverse event after Bayer Animal Health product application, you can transfer the information to us directly by:


Email:pv.bsah@bayer.com

To ask other question about Bayer China, please send e-mail to webmaster.china@bayer.com .


close
Bayer Global
Corporate Governance
Bayer in Compliance with Recommendations of the Corporate Governance Code
Corporate governance comprises the entire system of managing and supervising an enterprise. The Board of Management and the Supervisory Board of Bayer AG are committed to a responsible and transparent style of management and supervision aimed at increasing the company’s value over the long term.
Bayer has always placed great importance on responsible corporate governance. The company was able to issue a declaration that it had complied with the recommendations of the German Corporate Governance Code in the past but the following recommendations will not be complied with on one occasion.
The Supervisory Board has set up five committees – the Presidial Committee, the Audit Committee, the Human Resources Committee, the Nominations Committee and the Innovation Committee – and entrusted them with certain tasks in accordance with the German Stock Corporation Act and the German Corporate Governance Code.
Duties and Activities of the Board of Management
The Board of Management runs the Company on its own responsibility with the goal of sustainably increasing the company’s enterprise value and achieving defined corporate objectives. The Board of Management performs its tasks according to the law, the Articles of Incorporation and the Board’s rules of procedure, and works with the company’s other governance bodies in a spirit of trust.MORE
Supervisory Board: Oversight and Control Functions
The role of the 20-member Supervisory Board is to oversee and advise the Board of Management. Under the German Codetermination Act, half the Supervisory Board’s members are elected by the stockholders, and half by the company’s employees. MORE
Disclosure of Securities Transactions
Members of the Board of Management and Supervisory Board and their close relatives are legally required to disclose all transactions involving the purchase or sale of Bayer stock where such transactions total €5,000 or more in a calendar year. MORE
Statutory Target Numbers for the Proportion of Women in Senior Management Positions
Bayer is striving to improve the gender balance in management positions. The company has therefore set itself voluntary as well as statutory targets and pursues them consistently.MORE
Systematic Risk Management
The established control system enables the company to identify any business or financial risks at an early stage and take appropriate action to manage them. This control system is designed to ensure that risks are monitored in a timely manner, all business transactions are properly accounted for, and reliable data on the company’s financial position is always available. MORE
Corporate Compliance Program
Our corporate activity is governed by national and local laws and statutes that place a range of obligations on the Bayer Group and its employees throughout the world. Bayer manages its business responsibly and in compliance with the statutory and regulatory requirements of the countries in which it operates.MORE
Detailed Reporting
To maximize transparency, we provide regular and timely information on the Group’s position and significant changes in business activities to stockholders, financial analysts, stockholders’ associations, the media and the general public.
Search
Follow Us
Last updated:2019-07-19
Top